| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |